Scientists identify a possible new treatment for diabetic retinopathy
(PHYSorg.com Medicine & Health)

About one in three diabetic patients develops diabetic retinopathy (DR), which can impair vision and lead to blindness. A new study in The American Journal of Pathology, published by Elsevier, provides clear evidence that high glucose increases the levels of enzymatic precursor-lysyl oxidase propeptide (LOX-PP)-that promotes cell death, which was verified in an animal model of diabetes. These findings may help develop novel DR treatments by targeting LOX-PP or its metabolites.